Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a medicine that mimics a natural gut hormone released after eating.

Tirzepatide is a once-weekly injectable medication that simultaneously activates two gut hormone receptors.

Liraglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone released from the gut after eating.

Retatrutide is an injectable peptide drug that simultaneously activates three hormone receptors — GIP, GLP-1, and glucagon receptors.

Exenatide is a synthetic peptide that mimics glucagon-like peptide-1 (GLP-1), a hormone naturally released in the gut after eating.

Dulaglutide is a once-weekly injectable medication belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class.

Cagrilintide is a long-acting synthetic analogue of amylin, a hormone naturally released by the pancreas alongside insulin to help regulate appetite.

AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone, specifically.

Pramlintide is a synthetic analog of amylin, a hormone naturally co-secreted with insulin by the pancreatic beta cells at mealtimes.

Survodutide (also known as BI 456906) is an injectable peptide that simultaneously activates two hormone receptors in the body — the glucagon receptor.

Mazdutide (also known as IBI362) is a once-weekly injectable peptide that simultaneously activates two hormone receptors in the body.

Amycretin is a first-in-class, single-molecule drug that simultaneously activates two complementary appetite-regulating pathways in the body: the…

Efpeglenatide is a once-weekly injectable medication belonging to the GLP-1 receptor agonist (GLP-1 RA) class — a family of drugs.

Lixisenatide is a synthetic peptide that mimics glucagon-like peptide-1 (GLP-1), a natural hormone released from the gut after meals.